METHOD OF TREATING SYSTEMIC SCLEROSIS WITH SYMPTOMATIC RAYNAUD'S PHENOMENON BY INTRAVENOUS OR SUBCUTANEOUS ILOPROST ADMINISTRATION

The present disclosure generally relates to treatment of systemic sclerosis with symptomatic Raynaud's Phenomenon by intravenous or subcutaneous administration of iloprost or a pharmaceutically acceptable salt thereof.

Saved in:
Bibliographic Details
Main Authors CHRISTAL, Kevin A, BENTON, Wade W
Format Patent
LanguageEnglish
Published 12.09.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure generally relates to treatment of systemic sclerosis with symptomatic Raynaud's Phenomenon by intravenous or subcutaneous administration of iloprost or a pharmaceutically acceptable salt thereof.
Bibliography:Application Number: US202118260778